CClinicalTrials.gg
Not yet recruitingNCT05958953PROACT PROMUpdated Jul 25, 2023

PeRinatal Outcomes With ACTive Versus Expectant Management of Women With Pre-labor Rupture Of Membranes

A Phase 3 interventional study of Induction of Labor IoL in Rupture of Membranes; Premature, Distress; Fetal, Complicating Delivery and Delayed Delivery After Spontaneous or Unspecified Rupture of Membranes, sponsored by University of Modena and Reggio Emilia. Not yet recruiting at 1 site in Italy. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-25.

Sponsored by University of Modena and Reggio Emilia · Phase 3, Interventional, and Prevention

Phase
Phase 3
Study type
Interventional
Enrollment
1,400
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Term pre-labor rupture of membranes (PROM) occurs in about 12% of pregnancies and the time between PROM and delivery increases the risk of maternal/fetal infections. However, conflicting results are reported by studies investigating risks and benefits of expectant management versus induction of labor (IOL). Expectant management was associated with maternal and fetal infectious complications and subsequent increased risk of maternal and neonatal morbidity. Studies suggest that the increase in infectious risk for both is proportional to the increase in the time interval between the ROM and the birth, others reject this assumption.

In PeRinatal Outcomes With ACTive Versus Expectant Management of Women With Pre-labor Rupture Of Membranes (PROACTIVE PROM) on admission, PROM will be diagnosed. After 6 hours from the rupture of membranes, the woman will then be assessed for eligibility. A 1:1 randomization will follow within two hours (6-8 hours from PROM) in two distinct arms: 1) Expectant management 2) Active menagement (early IOL within 8 hours of rupture of membranes).

The first objective of this study is to evaluate whether active management of women with PROM (early induction) reduces the newborn need of respiratory support.

The secondary objectives of this study are related to the safety of the active management assessed through the rate of stillbirths, the onset of infections in both mother and fetus and the length of hospitalization of the dyads. Moreover, another objective is to reduce the use of antibiotic treatments (ATB) in both mothers and newborns.

The rationale of this study is that reducing the time between the PROM and delivery through an early IOL will reduce the adverse maternal and neonatal outcomes.

The hypothesis underneath this trial comes from a preliminary retrospective cohort study conducted in Modena, which included 2689 mother-neonates dyads from singleton pregnant women at term. In deliveries of ROM >24 hours significantly more neonates required ventilatory support than those born within 24 hours, although no significant differences were found regarding overt infections. According to the Cochrane database, expectant management of PROM is associated with maternal and fetal infectious complications and subsequent increased risk of maternal and neonatal morbidity together with an increased risk of ATB use. The increase of infectious risk is proportional to the time elapsed since the rupture of the membranes (ROM) and birth. However, unpublished data from our group suggest that respiratory distress requiring interventions may be frequently caused by intrinsic inflammatory-related effects of prolonged ROM rather than infection; this is suggested by an increase of C-reactive protein levels in neonates with mild respiratory signs untreated with antibiotics.

In addition, in a survey performed in our country expectant management increased intrapartum antibiotic prophylaxis (IAP), although not strictly indicated by the most current guidelines.

On the light of these data, it appears reasonable to promote induction of labor, to prevent complication caused not only by the infectious risk mentioned above, but also respiratory distress, probably associated to a neonatal maladaptation, in non-infectious newborns.

On the other hand, it should also be considered that 75% of women enter labor spontaneously within 24 hours from PROM and induction of labor (IOL) might not be needed in such cases.

02

Conditions studied

  • Rupture of Membranes; Premature
  • Distress; Fetal, Complicating Delivery
  • Delayed Delivery After Spontaneous or Unspecified Rupture of Membranes
  • Maternal Sepsis
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  1. Age ≥18 years of age at the time of randomization
  2. Gestational age ≥ 37 weeks
  3. Negative rectovaginal GBS swab
  4. Absent/poor uterine contractile activity 6 h after PROM (0-2 contractions /10 min)
  5. Cephalic presentation
  6. Ability to provide an informed consent
  7. Signed informed consent

Exclusion criteria

Exclusion Criteria:

  1. Prematurity (\<37 weeks)
  2. GBS positive vagino-rectal swab or with an unknown swab
  3. Multiple pregnancies
  4. Previous cesarean section (CS)
  5. Breech presentation, transverse lie or other indication for elective CS
  6. Suspected clinic for intra-amniotic infection (According to the Triple I criteria)
  7. Stained amniotic fluid
  8. Alterations of the FHR
  9. Unknown exact ROM time
  10. Known hypersensitivity to drugs for IOL or their excipients
  11. Presence of unknown vaginal bleeding
  12. Presence of maternal kidney disease (GFR \<15 ml/min/1,73 m2).
  13. Every condition contraindicating vaginal delivery
04

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,400 participants (estimated)

Study arms

  • Experimental
    active management

    early IOL within 8 hours of rupture of membranes. Center-specific IOL protocols will be used.

    Procedure: Induction of Labor IoL

  • No intervention
    Expectant management

    monitoring until 24 hours from rupture of membranes, with subsequent induction of labor (IOL).

Interventions

  • ProcedureInduction of Labor IoL

    Center-specific IOL protocols, based on international guidelines, will be used.

05

What researchers measure

Primary outcomes

  1. Rate of respiratory support in newborns

    The primary objective of this study is to evaluate whether active management of women with PROM (early induction) reduces the newborn need of respiratory support, collecting data on Apgar score, neonatal blood gas analysis and the rate of respiratory distress after birth and rate of respiratory support divided by type. The need for neonatal ventilatory support will be evaluated at delivery and include at least one of the following measures: free flowing oxygen in incubator, low flow oxygen (\<2 LPM), high flow oxygen (\>3 LPM), NCPAP or other NIV, mechanical ventilation.

    Time frame: On day 1 or 2 post-partum all relevant delivery and post-partum as well as neonatal variables will be collected.

Secondary outcomes

  1. Stillbirth and infection rate

    This secondary objectives of this study are related to the safety of the active management assessed through the rate of stillbirths, the onset of infections in the mother and fetus and through the length of hospitalization of the dyads. Moreover, another objective is to reduce the use of antibiotic treatments (ATB) in both mothers and newborns.

    Time frame: On day 1 or 2 post-partum all relevant delivery and post-partum as well as neonatal variables will be collected.

  2. length of hospitalization expressed in days

    The lenght of hospitalization and the need for re-hospitalizations are related to the safety of the active management assessed through the rate of stillbirths, the onset of infections in the mother and fetus and through the length of hospitalization of the dyads. Moreover, another objective is to reduce the use of antibiotic treatments (ATB) in both mothers and newborns.

    Time frame: From day 1 after delivery to the end of the puerperium (42 days after delivery)

  3. use of antibiotics in both mother and newborn as quantity (mg) and quality.

    The use of antibiotics will be recorded

    Time frame: From admission in the Hospital to 42 days after delivery

  4. neonatal infection as the yield of pathogen from blood or CFS coltures

    Suspected infection is based on the presence of clinical symptoms (neonatal tachycardia, hyperpyrexia, alteration of the skin color) and abnormal laboratory markers, i.e. an increase in C reactive proteins above 1.5 mg/dl.

    Time frame: From birth to 42 days after delivery

  5. Rate of Pathogen isolation in placenta's speciemen

    Placentas and umbilical cord will be collected only in the Milano Buzzi center

    Time frame: Collection of speciemens immediately after delivery

06

Study locations

1 site
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05958953
Lead sponsor
University of Modena and Reggio Emilia
Responsible party
Prof. Fabio Facchinetti (Full professor of Obstetrics and Gynecology Chairmen Unit of Obstetrics and Gynecology, University of Modena and Reggio Emilia) — Principal investigator
First posted
Jul 25, 2023
Start date
Sep 2023 (estimated)
Primary completion
Oct 2025 (estimated)
Completion
Nov 12, 2025 (estimated)
Last update
Jul 25, 2023

Study contacts

Fabio Facchinetti, Professor
Contact
fabio.facchinetti@unimore.it
0039 059 4225334

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion